Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

705 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased Arbekacin Clearance in Patients With Febrile Neutropenia.
Nakayama T, Chuma M, Tochikura N, Iwabuchi S, Suzuki S, Matsumoto C, Imai T, Hamada T, Nakagawa M, Takahashi H, Uchino Y, Miura K, Iriyama N, Hatta Y, Takei M, Kimura T. Nakayama T, et al. Among authors: matsumoto c. Ther Drug Monit. 2020 Feb;42(1):133-138. doi: 10.1097/FTD.0000000000000678. Ther Drug Monit. 2020. PMID: 31323015
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study).
Tanzawa S, Makiguchi T, Tasaka S, Inaba M, Ochiai R, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Miyamoto Y, Yokoyama T, Matsumoto C, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Seki N. Tanzawa S, et al. Among authors: matsumoto c. Ther Adv Med Oncol. 2022 Jul 29;14:17588359221116603. doi: 10.1177/17588359221116603. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35923924 Free PMC article.
Prognostic impact of 1q abnormality on outcomes in patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone in a real-world clinical setting.
Kikuchi T, Tsukada N, Kunisada K, Matsumoto C, Nomura-Yogo M, Oda Y, Sato K, Takei T, Ogura M, Abe Y, Suzuki K, Hosoya O, Ishida T. Kikuchi T, et al. Among authors: matsumoto c. Ann Hematol. 2024 Jun 6. doi: 10.1007/s00277-024-05835-4. Online ahead of print. Ann Hematol. 2024. PMID: 38839622 No abstract available.
Evaluation of pediatric patients for intestinal transplantation in the modern era.
Bryan NS, Russell SC, Ozler O, Sugiguchi F, Yazigi NA, Khan KM, Ekong UD, Vitola BE, Guerra JF, Kroemer A, Fishbein TM, Matsumoto CS, Ghobrial SS, Kaufman SS. Bryan NS, et al. Among authors: matsumoto cs. J Pediatr Gastroenterol Nutr. 2024 Jun 3. doi: 10.1002/jpn3.12274. Online ahead of print. J Pediatr Gastroenterol Nutr. 2024. PMID: 38828781
705 results